跳至主要内容
临床试验/NCT06174129
NCT06174129已完成不适用

Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes: A Case-Control Study

Burapha University1 个研究点 分布在 1 个国家目标入组 427 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
427
试验地点
1
主要终点
Prevalence of atrial fibrillation

研究概览

简要总结

This case-control study was conducted at Burapha University Hospital. The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Outpatients with type 2 diabetes who visited the medical clinic between June 2022 and June 2023

排除标准

  • Patients with missing information on the urinary albumin value and electrocardiograms at the latest date

结局指标

主要结局

Prevalence of atrial fibrillation

时间窗: June 2022 and June 2023

Prevalence of atrial fibrillation in patients with type 2 diabetes

Factors associated with atrial fibrillation

时间窗: June 2022 and June 2023

Factors associated with atrial fibrillation in patients with type 2 diabetes, including age, hypertension, heart failure, thyroid disease, type 2 diabetes duration, body mass index, estimated glomerular filtration rate, glycated hemoglobin, presence of albuminuria, and use of diuretic medications

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sukrisd Koowattanatianchai

Assistant Professor Dr.

Burapha University

研究点 (1)

Loading locations...

相似试验